TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
Tizona Therapeutics, Inc
Fate Therapeutics
Georgetown University
Masonic Cancer Center, University of Minnesota
Bristol-Myers Squibb
Merrimack Pharmaceuticals
Medical University Innsbruck
Harrison Clinical Research